NewcelX Ltd (NCEL)

• Market cap: $12.4M
• 1 day: -0.73%
• 5 days: -4.9%
• 1 month: 0.37%
• 3 months: -9.03%
• 6 months: -87.17%
• Year to date: 30.14%
• 1 year: -82.45%
• 5 years: -99.84%
• 10 years: -99.76%
• Sector: Healthcare
• Industry: Biotechnology

About: NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Employees: 11